138 related articles for article (PubMed ID: 29460712)
1. Rhythmic low-field magnetic stimulation may improve depression by increasing brain-derived neurotrophic factor.
Xiao L; Correll CU; Feng L; Xiang YT; Feng Y; Hu CQ; Li R; Wang G
CNS Spectr; 2019 Jun; 24(3):313-321. PubMed ID: 29460712
[TBL] [Abstract][Full Text] [Related]
2. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.
Ninan PT; Shelton RC; Bao W; Guico-Pabia CJ
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():86-91. PubMed ID: 24096053
[TBL] [Abstract][Full Text] [Related]
3. High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors.
Yukimasa T; Yoshimura R; Tamagawa A; Uozumi T; Shinkai K; Ueda N; Tsuji S; Nakamura J
Pharmacopsychiatry; 2006 Mar; 39(2):52-9. PubMed ID: 16555165
[TBL] [Abstract][Full Text] [Related]
4. Predictors of response to synchronized transcranial magnetic stimulation for major depressive disorder.
Philip NS; Leuchter AF; Cook IA; Massaro J; Goethe JW; Carpenter LL
Depress Anxiety; 2019 Mar; 36(3):278-285. PubMed ID: 30480860
[TBL] [Abstract][Full Text] [Related]
5. Alterations in Serum BDNF and GDNF Levels after 12 Weeks of Antidepressant Treatment in Female Outpatients with Major Depressive Disorder.
Park YM; Lee BH
Psychiatry Investig; 2018 Aug; 15(8):818-823. PubMed ID: 29945425
[TBL] [Abstract][Full Text] [Related]
6. The roles of brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) in predicting treatment remission in a Chinese Han population with generalized anxiety disorder.
Shen Z; Zhu J; Yuan Y; Ren L; Qian M; Lin M; Cai M; Zhang Z; Shen X
Psychiatry Res; 2019 Jan; 271():319-324. PubMed ID: 30529313
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of brain-derived neurotrophic factor are unchanged after transcranial direct current stimulation in treatment-resistant depression.
Palm U; Fintescu Z; Obermeier M; Schiller C; Reisinger E; Keeser D; Pogarell O; Bondy B; Zill P; Padberg F
J Affect Disord; 2013 Sep; 150(2):659-63. PubMed ID: 23664268
[TBL] [Abstract][Full Text] [Related]
8. [Dynamic level observation of brain-derived neurotrophic factor in patients with first-episode generalized anxiety disorder].
Shen XH; Qian MC; Niu FR; Sun ST; Zhu YP; Yang JH; Lin M; Yu BR; Li L; Shen ZX
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(41):2939-41. PubMed ID: 22333619
[TBL] [Abstract][Full Text] [Related]
9. Serum brain-derived neurotrophic factor, Val66Met polymorphism and open-label SSRI treatment response in Major Depressive Disorder.
Smit AJT; Wu GWY; Rampersaud R; Reus VI; Wolkowitz OM; Mellon SH
Psychoneuroendocrinology; 2024 Jul; 165():107045. PubMed ID: 38636352
[TBL] [Abstract][Full Text] [Related]
10. International randomized-controlled trial of transcranial Direct Current Stimulation in depression.
Loo CK; Husain MM; McDonald WM; Aaronson S; O'Reardon JP; Alonzo A; Weickert CS; Martin DM; McClintock SM; Mohan A; Lisanby SH;
Brain Stimul; 2018; 11(1):125-133. PubMed ID: 29111077
[TBL] [Abstract][Full Text] [Related]
11. Brain-derived neurotrophic factor in generalized anxiety disorder: results from a duloxetine clinical trial.
Ball S; Marangell LB; Lipsius S; Russell JM
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():217-21. PubMed ID: 23313564
[TBL] [Abstract][Full Text] [Related]
12. Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depression.
Dreimüller N; Schlicht KF; Wagner S; Peetz D; Borysenko L; Hiemke C; Lieb K; Tadić A
Neuropharmacology; 2012 Jan; 62(1):264-9. PubMed ID: 21803060
[TBL] [Abstract][Full Text] [Related]
13. Effects of electroconvulsive therapy and repetitive transcranial magnetic stimulation on serum brain-derived neurotrophic factor levels in patients with depression.
Gedge L; Beaudoin A; Lazowski L; du Toit R; Jokic R; Milev R
Front Psychiatry; 2012; 3():12. PubMed ID: 22375129
[TBL] [Abstract][Full Text] [Related]
14. Low-frequency repetitive transcranial magnetic stimulation in the right prefrontal cortex combined with partial sleep deprivation in treatment-resistant depression: a randomized sham-controlled trial.
Krstić J; Buzadžić I; Milanović SD; Ilić NV; Pajić S; Ilić TV
J ECT; 2014 Dec; 30(4):325-31. PubMed ID: 24625704
[TBL] [Abstract][Full Text] [Related]
15. Prelimbic Stimulation Ameliorates Depressive-Like Behaviors and Increases Regional BDNF Expression in a Novel Drug-Resistant Animal Model of Depression.
Moshe H; Gal R; Barnea-Ygael N; Gulevsky T; Alyagon U; Zangen A
Brain Stimul; 2016; 9(2):243-50. PubMed ID: 26655599
[TBL] [Abstract][Full Text] [Related]
16. Changes in miRNA-132 and miR-124 levels in non-treated and citalopram-treated patients with depression.
Fang Y; Qiu Q; Zhang S; Sun L; Li G; Xiao S; Li X
J Affect Disord; 2018 Feb; 227():745-751. PubMed ID: 29689690
[TBL] [Abstract][Full Text] [Related]
17. Repetitive transcranial magnetic stimulation increases serum brain-derived neurotrophic factor and decreases interleukin-1β and tumor necrosis factor-α in elderly patients with refractory depression.
Zhao X; Li Y; Tian Q; Zhu B; Zhao Z
J Int Med Res; 2019 May; 47(5):1848-1855. PubMed ID: 30616482
[TBL] [Abstract][Full Text] [Related]
18. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
19. Plasma Brain-Derived Neurotrophic Factor Levels in First-Episode and Recurrent Major Depression and before and after Bright Light Therapy in Treatment-Resistant Depression.
Kosanovic Rajacic B; Sagud M; Begic D; Nikolac Perkovic M; Dvojkovic A; Ganoci L; Pivac N
Biomolecules; 2023 Sep; 13(9):. PubMed ID: 37759825
[TBL] [Abstract][Full Text] [Related]
20. Potential value of serum brain-derived neurotrophic factor, vascular endothelial growth factor, and S100B for identifying major depressive disorder in knee osteoarthritis patients.
Zhang P; Xiong Y; Wang B; Zhou Y; Wang Z; Shi J; Li C; Lu X; Chen G
Front Psychiatry; 2022; 13():1019367. PubMed ID: 36386998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
